These are self-pay prices and do not take into account any discounts or prescription insurance coverage that you may have. Actual prices are calculated at the time your prescription is processed by the pharmacy.
FDA approves generic version of Wyeth reflux drug The Food and Drug Administration granted final approval Thursday to Teva Pharmaceutical Industries' application to market a generic version of Wyeth's acid reflux drug Protonix. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
340B Prime Vendor Program: The 340B Prime Vendor Program Adds Wyeth Pharmaceuticals' PROTONIX(R) to Its Growing List of Branded Drugs for Participants IRVING, TX (MARKET WIRE) The 340B Prime Vendor Program, managed by HealthCare Purchasing Partners International(R) (HPPI) announced today that it has added Wyeth Pharmaceuticals to its list of contracted suppliers and will extend sub-ceiling discounts on PROTONIX(R) delayed-release tablets to participants of the program. PROTONIX is a proton pump inhibitor indicated for the treatment and maintenance of healing of erosive esophagitis with (Source: Market Wire - Pharmaceuticals and Biotech)
